Article
Inhibition of Uropathogenic Escherichia coli by Cranberry Juice: A New Antiadherence Assay
UIC/NIH Center for Botanical Dietary Supplements Research for Women's Health.
Laboratory for Molecular Biology.
Antimicrobial Research Center, Pharmacy Practice (MC866).
To whom correspondence should be addressed. Tel: 312-996-7254. Fax: 312-996-7017. E-mail: norman@uic.edu.
Abstract
A combination of microplate technology and turbidity assessment for testing the adherence of P-fimbriated Escherichia coli to human uroepithelial cell line T24, validated with the addition of the known inhibitor 4-O-α-d-galactopyranosyl-α-d-galactopyranose (galabiose), resulted in a high-throughput, biologically relevant assessment of cranberry (Vaccinium macrocarpon). P-fimbriated ATCC E. coli strains 25922, 29194, and 49161 were inhibited by galabiose. ATCC 29194, a representative urine isolate containing the papGII allele (Class II fimbrial adhesin) and demonstrating the most significant inhibition in the presence of galabiose, was chosen for further testing. In this assay, a low-polarity fraction of cranberry juice cocktail demonstrated dose-dependent inhibition of E. coli adherence. Reported here, for the first time in V. macrocarpon, are 1-O-methylgalactose, prunin, and phlorizin, identified in an active fraction of cranberry juice concentrate. This in vitro assay will be useful for the standardization of cranberry dietary supplements and is currently being used for bioassay-guided fractionation of cranberry juice concentrate.
Keywords: Escherichia coli; cranberry; Vaccinium macrocarpon; uroepithelial; bacterial adhesin; bacterial adhesion; papG protein; P-fimbriae; 1-methoxygalactose; prunin; phloridzin; α-d-galactopyranosyl-(1→4)-α-d-galactopyranose; galabiose; botanical dietary supplement standardization
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue November 16, 2005
- Received for review August 18, 2005. Accepted August 23, 2005. Research was generously supported by Grant P50AT00155 and an NRSA Fellowship for A.T. (F3AT00623) from the National Center for Complementary and Alternative Medicine (NCCAM), the Office of Dietary Supplements (ODS), the Office for Research on Women's Health (ORWH), and the National Institute of General Medical Sciences (NIGMS). The contents are solely the responsibility of the authors and do not necessarily represent official views of NCCAM, ODS, ORWH, or NIGMS.
Cart


